Debajyoti Roy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Debajyoti Roy has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Sreekanth Koduri
Nephrology, Changi General Hospital, Singapore, SGP
3 shared publicationsWenxiang Yeon
Department of Renal Medicine Changi General Hospital Singapore
3 shared publicationsChang Yin Chionh
Department of Renal Medicine Changi General Hospital Singapore
2 shared publicationsChee Yong Ng
Department of Renal Medicine Changi General Hospital Singapore
2 shared publications- Jia Wen Kam
Clinical Trials & Research Unit, Changi General Hospital, 2 Simei St 3, Singapore 529889, Singapore
2 shared publications Jiashen Cai
2 shared publications
Latest Publications
- Open Access
- 3 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Vaccination Challenges and Outcomes in Patients Undergoing Hemodialysis: Experience From a Pharmacist-Led Program in Singapore
Background Patients receiving maintenance hemodialysis experience a high burden of infectious morbidity, and vaccination is a key preventive strategy in this population. Despite international guideline recommendations, vaccination uptake and immune response in this population remain suboptimal. Aims The study aimed to evaluate hepatitis B virus (HBV) vaccination completion and seroprotection, pneumococcal vaccination coverage, and pneumonia-related hospitalizations among incident hemodialysis patients managed under a pharmacist-led vaccination program. Design This retrospective cohort study was conducted between 2019 and 2022 at a tertiary hospital dialysis program in Singapore, where vaccination delivery was integrated into routine hemodialysis care by clinical pharmacists. Methods All consecutive incident adult hemodialysis patients managed between January 2019 and December 2022 under a pharmacist-led vaccination model were included. They were evaluated for vaccination uptake, immune response to HBV vaccination, and pneumonia-related hospitalizations within the first year of dialysis initiation. Data were extracted from the hospital’s electronic medical record (EMR) system. As this was a service evaluation of the entire eligible population during the study period, no formal sample size calculation was performed. Statistical analysis Categorical variables were analyzed using chi-square testing, with statistical significance defined as a two-sided p-value < 0.05. Results are reported with corresponding chi-square statistics and p-values where applicable. Results Among HBV-susceptible patients, just over one-third completed the recommended three-dose vaccination schedule, and approximately half of those achieved seroprotection. Pneumococcal vaccination coverage within the first year of hemodialysis initiation was below 50%. Pneumonia-related hospitalizations were lower among vaccinated patients (2.2%) compared with unvaccinated patients (7.5%) and were statistically significant (p = 0.032). Conclusions A pharmacist-led vaccination program was associated with moderate vaccine uptake and reduced pneumonia-related hospitalizations; however, substantial gaps in vaccination completion and immune response persisted. Multicomponent, system-level strategies may be required to enhance vaccine uptake and effectiveness in hemodialysis populations.
- 3 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Open AccessVaccination Challenges and Outcomes in Patients Undergoing Hemodialysis: Experience From a Pharmacist-Led Program in Singapore
Background Patients receiving maintenance hemodialysis experience a high burden of infectious morbidity, and vaccination is a key preventive strategy in this population. Despite international guideline recommendations, vaccination uptake and immune response in this population remain suboptimal. Aims The study aimed to evaluate hepatitis B virus (HBV) vaccination completion and seroprotection, pneumococcal vaccination coverage, and pneumonia-related hospitalizations among incident hemodialysis patients managed under a pharmacist-led vaccination program. Design This retrospective cohort study was conducted between 2019 and 2022 at a tertiary hospital dialysis program in Singapore, where vaccination delivery was integrated into routine hemodialysis care by clinical pharmacists. Methods All consecutive incident adult hemodialysis patients managed between January 2019 and December 2022 under a pharmacist-led vaccination model were included. They were evaluated for vaccination uptake, immune response to HBV vaccination, and pneumonia-related hospitalizations within the first year of dialysis initiation. Data were extracted from the hospital’s electronic medical record (EMR) system. As this was a service evaluation of the entire eligible population during the study period, no formal sample size calculation was performed. Statistical analysis Categorical variables were analyzed using chi-square testing, with statistical significance defined as a two-sided p-value < 0.05. Results are reported with corresponding chi-square statistics and p-values where applicable. Results Among HBV-susceptible patients, just over one-third completed the recommended three-dose vaccination schedule, and approximately half of those achieved seroprotection. Pneumococcal vaccination coverage within the first year of hemodialysis initiation was below 50%. Pneumonia-related hospitalizations were lower among vaccinated patients (2.2%) compared with unvaccinated patients (7.5%) and were statistically significant (p = 0.032). Conclusions A pharmacist-led vaccination program was associated with moderate vaccine uptake and reduced pneumonia-related hospitalizations; however, substantial gaps in vaccination completion and immune response persisted. Multicomponent, system-level strategies may be required to enhance vaccine uptake and effectiveness in hemodialysis populations.
- Open Access
- 3 September 2025
- Published by Springer Nature in Cureus
- Vol. 17 (9) , e91523
Recurrent Acute Kidney Injury Due to Atheroembolic Renal Disease: Diagnostic Utility of Fundoscopy
Atheroembolic renal disease (AERD) is a rare and often underdiagnosed cause of acute kidney injury (AKI), particularly in patients with atherosclerotic disease. We present the case of a 66-year-old man with hypertension, hyperlipidemia, and stage 3 chronic kidney disease (CKD) (baseline creatinine 100-120 μmol/L) who developed AKI after coronary artery bypass graft (CABG) for non-ST-elevation myocardial infarction (NSTEMI), followed by recurrent episodes and progressive renal decline despite no further invasive procedures. Fundoscopic examination revealed Hollenhorst plaques, leading to a clinical diagnosis of AERD. This case underscores the diagnostic value of noninvasive ophthalmologic evaluation in patients at high risk for cholesterol embolism. The patient was managed with supportive measures, including hydration and blood pressure control, which helped stabilize renal function (creatinine improved from 591 to 410 μmol/L). Our objective is to highlight the diagnostic utility of fundoscopy in evaluating unexplained renal deterioration and systemic ischemic symptoms in frail patients where biopsy is contraindicated.
- 3 September 2025
- Published by Springer Nature in Cureus
- Vol. 17 (9) , e91523
Open AccessRecurrent Acute Kidney Injury Due to Atheroembolic Renal Disease: Diagnostic Utility of Fundoscopy
Atheroembolic renal disease (AERD) is a rare and often underdiagnosed cause of acute kidney injury (AKI), particularly in patients with atherosclerotic disease. We present the case of a 66-year-old man with hypertension, hyperlipidemia, and stage 3 chronic kidney disease (CKD) (baseline creatinine 100-120 μmol/L) who developed AKI after coronary artery bypass graft (CABG) for non-ST-elevation myocardial infarction (NSTEMI), followed by recurrent episodes and progressive renal decline despite no further invasive procedures. Fundoscopic examination revealed Hollenhorst plaques, leading to a clinical diagnosis of AERD. This case underscores the diagnostic value of noninvasive ophthalmologic evaluation in patients at high risk for cholesterol embolism. The patient was managed with supportive measures, including hydration and blood pressure control, which helped stabilize renal function (creatinine improved from 591 to 410 μmol/L). Our objective is to highlight the diagnostic utility of fundoscopy in evaluating unexplained renal deterioration and systemic ischemic symptoms in frail patients where biopsy is contraindicated.
- Open Access
- 25 August 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-15
Predicting mortality in elderly chronic kidney disease patients using algorithmic risk assessment: a Southeast Asian perspective
The global burden of chronic kidney disease (CKD) in elderly patients is rising, presenting significant management challenges. These patients often experience rapid cognitive and physical decline following dialysis initiation, complicating treatment decisions. Given that age alone is an insufficient criterion for identifying candidates likely to benefit from dialysis, an optimal shared decision-making model should integrate clinical parameters related to comorbid conditions, as well as patient-centered factors such as individual values and treatment preferences. Traditional models, such as the REIN and Wick scores, use predefined linear relationships and are often based on Western populations, limiting their generalizability. Machine learning (ML) offers an innovative approach by identifying complex, nonlinear relationships in diverse datasets, potentially improving predictive accuracy. This study aimed to develop ML models to predict six-month mortality in elderly patients initiating haemodialysis. We used data from a single-center cohort of 1,606 patients with advanced CKD, aged ≥65 years, who initiated haemodialysis at Changi General Hospital, Singapore, between January 2015 and October 2023. Specifically, random forest and balanced random forest models were developed and their predictive performance was compared with existing prognostic tools. Both models incorporated feature importance rankings determined by SHapley Additive exPlanations (SHAP). The normal random forest model marginally outperformed the balanced random forest model, achieving an area under the receiver operating characteristic curve (ROC-AUC) of 0.83 (95% CI 0.775 – 0.874) versus 0.82 (95% CI: 0.772 – 0.873). Both models demonstrated superior performance and calibration compared to conventional tools. This study demonstrates that ML-based models may offer modest improvements in predicting six-month mortality in elderly patients with end-stage renal disease (ESRD). These tools could support, but not replace, shared decision-making by providing additional prognostic insights alongside clinical judgment. Not applicable.
- 25 August 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-15
Open AccessPredicting mortality in elderly chronic kidney disease patients using algorithmic risk assessment: a Southeast Asian perspective
The global burden of chronic kidney disease (CKD) in elderly patients is rising, presenting significant management challenges. These patients often experience rapid cognitive and physical decline following dialysis initiation, complicating treatment decisions. Given that age alone is an insufficient criterion for identifying candidates likely to benefit from dialysis, an optimal shared decision-making model should integrate clinical parameters related to comorbid conditions, as well as patient-centered factors such as individual values and treatment preferences. Traditional models, such as the REIN and Wick scores, use predefined linear relationships and are often based on Western populations, limiting their generalizability. Machine learning (ML) offers an innovative approach by identifying complex, nonlinear relationships in diverse datasets, potentially improving predictive accuracy. This study aimed to develop ML models to predict six-month mortality in elderly patients initiating haemodialysis. We used data from a single-center cohort of 1,606 patients with advanced CKD, aged ≥65 years, who initiated haemodialysis at Changi General Hospital, Singapore, between January 2015 and October 2023. Specifically, random forest and balanced random forest models were developed and their predictive performance was compared with existing prognostic tools. Both models incorporated feature importance rankings determined by SHapley Additive exPlanations (SHAP). The normal random forest model marginally outperformed the balanced random forest model, achieving an area under the receiver operating characteristic curve (ROC-AUC) of 0.83 (95% CI 0.775 – 0.874) versus 0.82 (95% CI: 0.772 – 0.873). Both models demonstrated superior performance and calibration compared to conventional tools. This study demonstrates that ML-based models may offer modest improvements in predicting six-month mortality in elderly patients with end-stage renal disease (ESRD). These tools could support, but not replace, shared decision-making by providing additional prognostic insights alongside clinical judgment. Not applicable.
- Open Access
- 13 August 2025
- Published by Wiley in Aging Medicine
- Vol. 8 (4) , 279-285
Impact of Type 2 Diabetes Mellitus and Chronic Kidney Disease on Bone Mineral Density in Elderly Patients With Fragility Hip Fracture: A Cross‐Sectional Study
Objectives: Diabetes mellitus (DM) and chronic kidney disease (CKD) are prevalent conditions in the elderly population, increasing the risk of bone fractures due to their adverse effects on bone quality. This study aimed to assess their impact on bone health and propose interventions to mitigate fracture risk in this demographic.Methods: A cross‐sectional study involving 571 elderly patients (aged ≥ 65 years) with fragility hip fractures was conducted at a tertiary care hospital between June 2014 and June 2016. Patients were categorized into four groups based on DM and CKD presence. Bone mineral density (BMD) at the femoral neck was measured using dual‐energy X‐ray absorptiometry (DXA) scan. Statistical analysis included ANOVA with Bonferroni correction.Results: The mean age was 79.5 ± 7.3 years, with females comprising 70.6%. Group 2 (No CKD with diabetes) exhibited higher T‐scores than Group 1 (No CKD or Diabetes). Patients with DM had higher T‐scores, with an increase of 0.2 compared to those without DM and CKD. Surprisingly, CKD and DM coexistence (Group 4) did not worsen T‐scores. Higher HbA1c levels were positively associated with a higher T‐score, but this was lost in concurrent CKD.Conclusions: Patients with DM had higher T‐scores; the combination of CKD and DM did not worsen T‐scores. However, the positive association between higher HbA1c and higher T‐score was nullified in concurrent CKD. These findings emphasize the need for tailored interventions to mitigate fracture risk in elderly populations with DM and CKD.
- 13 August 2025
- Published by Wiley in Aging Medicine
- Vol. 8 (4) , 279-285
Open AccessImpact of Type 2 Diabetes Mellitus and Chronic Kidney Disease on Bone Mineral Density in Elderly Patients With Fragility Hip Fracture: A Cross‐Sectional Study
Objectives: Diabetes mellitus (DM) and chronic kidney disease (CKD) are prevalent conditions in the elderly population, increasing the risk of bone fractures due to their adverse effects on bone quality. This study aimed to assess their impact on bone health and propose interventions to mitigate fracture risk in this demographic.Methods: A cross‐sectional study involving 571 elderly patients (aged ≥ 65 years) with fragility hip fractures was conducted at a tertiary care hospital between June 2014 and June 2016. Patients were categorized into four groups based on DM and CKD presence. Bone mineral density (BMD) at the femoral neck was measured using dual‐energy X‐ray absorptiometry (DXA) scan. Statistical analysis included ANOVA with Bonferroni correction.Results: The mean age was 79.5 ± 7.3 years, with females comprising 70.6%. Group 2 (No CKD with diabetes) exhibited higher T‐scores than Group 1 (No CKD or Diabetes). Patients with DM had higher T‐scores, with an increase of 0.2 compared to those without DM and CKD. Surprisingly, CKD and DM coexistence (Group 4) did not worsen T‐scores. Higher HbA1c levels were positively associated with a higher T‐score, but this was lost in concurrent CKD.Conclusions: Patients with DM had higher T‐scores; the combination of CKD and DM did not worsen T‐scores. However, the positive association between higher HbA1c and higher T‐score was nullified in concurrent CKD. These findings emphasize the need for tailored interventions to mitigate fracture risk in elderly populations with DM and CKD.
- 3 January 2023
- Published by Wiley in Seminars in Dialysis
- Vol. 36 (2) , 170-174
Recalcitrant hypercalcemia in a dialysis patient: Case report, literature review, and proposed management algorithm
A 62‐year‐old male on maintenance hemodialysis, who was bedbound after a cerebrovascular accident, developed progressive hypercalcemia during a prolonged hospital stay. The etiology of hypercalcemia was attributed to immobility after extensive workup including imaging for malignancy or granulomatous disease, parathyroid hormone levels, parathyroid hormone related peptide, and vitamin D levels were unyielding. Low calcium dialysate would transiently reduce serum calcium levels, but levels would rebound in the interdialytic period. In view of recalcitrant hypercalcemia presenting with crisis, denosumab was successfully used to lower serum calcium. We review the literature and propose a management algorithm for severe hypercalcemia in a patient on dialysis.
- 3 January 2023
- Published by Wiley in Seminars in Dialysis
- Vol. 36 (2) , 170-174
Recalcitrant hypercalcemia in a dialysis patient: Case report, literature review, and proposed management algorithm
A 62‐year‐old male on maintenance hemodialysis, who was bedbound after a cerebrovascular accident, developed progressive hypercalcemia during a prolonged hospital stay. The etiology of hypercalcemia was attributed to immobility after extensive workup including imaging for malignancy or granulomatous disease, parathyroid hormone levels, parathyroid hormone related peptide, and vitamin D levels were unyielding. Low calcium dialysate would transiently reduce serum calcium levels, but levels would rebound in the interdialytic period. In view of recalcitrant hypercalcemia presenting with crisis, denosumab was successfully used to lower serum calcium. We review the literature and propose a management algorithm for severe hypercalcemia in a patient on dialysis.
- Open Access
- 21 October 2022
- Published by Frontiers Media SA in Frontiers in Aging
- Vol. 3, 1026663
25-OH vitamin D threshold for optimal bone mineral density in elderly patients with chronic kidney disease
Introduction: Vitamin D deficiency is common in chronic kidney disease (CKD) and is associated with lower bone mineral density (BMD), decreased muscle strength, and increased hip fracture risk. Guidelines have suggested targeting 25-OH vitamin D (25(OH)D) levels between 20 and 30 ng/ml. However, vitamin D metabolism is altered in CKD, and threshold levels for optimal BMD are unknown.Methods: We included 1097 patients with hip fractures. CKD was defined as estimated glomerular filtration rate Results: CKD was present in 479 (44%) patients. Using a threshold of 25(OH)D < 30 ng/ml, there were no significant differences in patients with CKD and low BMD when compared to the other groups. We identified 27 ng/ml as a better threshold with the Youden index. Using 25(OH)D < 27 ng/ml as a threshold, 360 of 482 patients (74.7%) with low 25(OH)D had low BMD, compared to only 185/276 (67%) of patients with adequate vitamin D, p = 0.02, which was irrespective of the presence or absence of CKD. Furthermore, patients with CKD and 25(OH)D < 27 ng/ml had a higher odds ratio of mortality upon follow-up, 1.61, 95% CI: 1.08–2.39, compared to those with CKD and 25(OH)D ≥ 27 ng/ml.Conclusion: We find that 25(OH)D < 27 ng/ml is associated with low BMD in patients with and without CKD. Further prospective studies targeting vitamin D repletion to at least 27 ng/ml and the outcome of hip fractures will be useful to validate these findings.
- 21 October 2022
- Published by Frontiers Media SA in Frontiers in Aging
- Vol. 3, 1026663
Open Access25-OH vitamin D threshold for optimal bone mineral density in elderly patients with chronic kidney disease
Introduction: Vitamin D deficiency is common in chronic kidney disease (CKD) and is associated with lower bone mineral density (BMD), decreased muscle strength, and increased hip fracture risk. Guidelines have suggested targeting 25-OH vitamin D (25(OH)D) levels between 20 and 30 ng/ml. However, vitamin D metabolism is altered in CKD, and threshold levels for optimal BMD are unknown.Methods: We included 1097 patients with hip fractures. CKD was defined as estimated glomerular filtration rate Results: CKD was present in 479 (44%) patients. Using a threshold of 25(OH)D < 30 ng/ml, there were no significant differences in patients with CKD and low BMD when compared to the other groups. We identified 27 ng/ml as a better threshold with the Youden index. Using 25(OH)D < 27 ng/ml as a threshold, 360 of 482 patients (74.7%) with low 25(OH)D had low BMD, compared to only 185/276 (67%) of patients with adequate vitamin D, p = 0.02, which was irrespective of the presence or absence of CKD. Furthermore, patients with CKD and 25(OH)D < 27 ng/ml had a higher odds ratio of mortality upon follow-up, 1.61, 95% CI: 1.08–2.39, compared to those with CKD and 25(OH)D ≥ 27 ng/ml.Conclusion: We find that 25(OH)D < 27 ng/ml is associated with low BMD in patients with and without CKD. Further prospective studies targeting vitamin D repletion to at least 27 ng/ml and the outcome of hip fractures will be useful to validate these findings.
- 28 April 2022
- Published by Springer Nature
- p. 197-207
Secondary Causes of Hypertension: An Overview
- Open Access
- 2 November 2021
- Published by Springer Nature in Cureus
- Vol. 13 (11)
An Uncommon Cause of Recurrent Dialysis Catheter-Related Bacteremia
A 54-year-old man on maintenance hemodialysis with recurrent catheter-related bloodstream infections due to Staphylococcus aureus was admitted. Multiple prior transthoracic echocardiograms failed to reveal any vegetation. Subsequently on transesophageal echocardiography a mass consistent with fibrin sheath vegetations was identified and a follow-up diagnostic computed tomography (CT) venogram confirmed the presence of a fibrin sheath with vegetations.
- 2 November 2021
- Published by Springer Nature in Cureus
- Vol. 13 (11)
Open AccessAn Uncommon Cause of Recurrent Dialysis Catheter-Related Bacteremia
A 54-year-old man on maintenance hemodialysis with recurrent catheter-related bloodstream infections due to Staphylococcus aureus was admitted. Multiple prior transthoracic echocardiograms failed to reveal any vegetation. Subsequently on transesophageal echocardiography a mass consistent with fibrin sheath vegetations was identified and a follow-up diagnostic computed tomography (CT) venogram confirmed the presence of a fibrin sheath with vegetations.
- Open Access
- 9 July 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (27) , e26625
Hip fractures in elderly patients with non-dialysis dependent chronic kidney disease
Chronic kidney disease (CKD) causes bone and mineral disorders and alterations in vitamin D metabolism that contribute to greater skeletal fragility. Hip fracture in elderly is associated with significant morbidity and mortality. The aim of this study was to investigate the outcome of elderly patients with non-dialysis dependent CKD and hip fracture undergoing surgery. Retrospective study with IRB approval of patients above 65 years of age, with hip fractures admitted between June 2014 to June 2016 in a Southeast Asian cohort. Data collected included demographic variables and the haematological and biochemical parameters HBA1c, estimated glomerular filtration rate (eGFR), serum calcium, phosphorous, and 25(OH) Vitamin D. Co-morbidities investigated were ischemic heart disease, congestive heart failure, peripheral vascular disease, malignancy, chronic obstructive pulmonary disease, cerebro vascular accident, hypertension and hyperlipidaemia. All patients were followed up from index date to either death or June 1, 2018. Of the 883 patients, 725 underwent surgery and 334 had CKD. Death rates for CKD patients with hip fractures and those with normal renal function did not differ significantly [8.08% vs 6.54%, (HR= 1.33, 95% CI: 0.95, 1.86; P = .102)], whilst median hospital length of stay was significantly higher in CKD patients [10.5 vs 9.03 days (P = .003)]. Significant risk factors associated with higher risk of mortality in the elderly with hip fracture were male gender, age ≥80 years and serum albumin < 30 g/L (all, P < .0001). In summary, in elderly, non-dialysis dependent CKD patient with hip fracture we found that male gender, age ≥80 years, low serum albumin and eGFR < 30 mL/min/1.73 m2 were associated with higher risk of death. The hospital stay in the CKD group was also longer. Additional studies are needed to validate our findings.
- 9 July 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (27) , e26625
Open AccessHip fractures in elderly patients with non-dialysis dependent chronic kidney disease
Chronic kidney disease (CKD) causes bone and mineral disorders and alterations in vitamin D metabolism that contribute to greater skeletal fragility. Hip fracture in elderly is associated with significant morbidity and mortality. The aim of this study was to investigate the outcome of elderly patients with non-dialysis dependent CKD and hip fracture undergoing surgery. Retrospective study with IRB approval of patients above 65 years of age, with hip fractures admitted between June 2014 to June 2016 in a Southeast Asian cohort. Data collected included demographic variables and the haematological and biochemical parameters HBA1c, estimated glomerular filtration rate (eGFR), serum calcium, phosphorous, and 25(OH) Vitamin D. Co-morbidities investigated were ischemic heart disease, congestive heart failure, peripheral vascular disease, malignancy, chronic obstructive pulmonary disease, cerebro vascular accident, hypertension and hyperlipidaemia. All patients were followed up from index date to either death or June 1, 2018. Of the 883 patients, 725 underwent surgery and 334 had CKD. Death rates for CKD patients with hip fractures and those with normal renal function did not differ significantly [8.08% vs 6.54%, (HR= 1.33, 95% CI: 0.95, 1.86; P = .102)], whilst median hospital length of stay was significantly higher in CKD patients [10.5 vs 9.03 days (P = .003)]. Significant risk factors associated with higher risk of mortality in the elderly with hip fracture were male gender, age ≥80 years and serum albumin < 30 g/L (all, P < .0001). In summary, in elderly, non-dialysis dependent CKD patient with hip fracture we found that male gender, age ≥80 years, low serum albumin and eGFR < 30 mL/min/1.73 m2 were associated with higher risk of death. The hospital stay in the CKD group was also longer. Additional studies are needed to validate our findings.
- 24 May 2021
- Published by Wiley in Internal Medicine Journal
- Vol. 52 (9) , 1531-1537
Serum anion gap revisited: a verified reference interval for contemporary use
Background: The anion gap (AG) is often used to evaluate acid–base disorders. The reference interval for normal AG is used to differentiate between raised (gap) or normal AG (non‐gap) acidosis. Historically accepted AG values may not be valid with the evolution of modern analytical techniques and the reference interval requires revalidation.Aims: To determine the reference interval for AG based on current laboratory techniques.Methods: During a health‐screening exercise, 284 participants with no major illnesses volunteered surplus blood for analysis. The samples were tested in an internationally accredited clinical laboratory. AG was calculated by [Na+] − [Cl−] − [HCO3−] and AGK by [Na+] + [K+] − [Cl−] − [HCO3−]. The reference interval was determined at 2.5th–97.5th percentiles. Analysis was further undertaken for a subcohort of 156 individuals with no suboptimal health indicators.Results: Median age was 35 years, body mass index 23.4 kg/m2 and the glomerular filtration rate was 106 mL/min/1.73 m2. Median AG was 13 mmol/L and the reference interval for normal AG is 10–18 mmol/L with a 99% level of confidence. Statistically significant differences in AG were detected for sex, race, obesity and serum albumin, but the difference was 1 mmol/L between subgroups. The reference interval was the same for the sub‐cohort of 156 individuals. Median AGK was 17.7 mmol/L and reference interval was 14.6–22.5 mmol/L.Conclusions: The AG reference interval of 10–18 mmol/L is valid for laboratories with similar reference intervals for electrolytes. Lower values expected with current laboratory techniques were not observed. The median AG of 13 mmol/L may be used to differentiate gap acidosis, non‐gap acidosis or mixed acid–base disorders.
- 24 May 2021
- Published by Wiley in Internal Medicine Journal
- Vol. 52 (9) , 1531-1537
Serum anion gap revisited: a verified reference interval for contemporary use
Background: The anion gap (AG) is often used to evaluate acid–base disorders. The reference interval for normal AG is used to differentiate between raised (gap) or normal AG (non‐gap) acidosis. Historically accepted AG values may not be valid with the evolution of modern analytical techniques and the reference interval requires revalidation.Aims: To determine the reference interval for AG based on current laboratory techniques.Methods: During a health‐screening exercise, 284 participants with no major illnesses volunteered surplus blood for analysis. The samples were tested in an internationally accredited clinical laboratory. AG was calculated by [Na+] − [Cl−] − [HCO3−] and AGK by [Na+] + [K+] − [Cl−] − [HCO3−]. The reference interval was determined at 2.5th–97.5th percentiles. Analysis was further undertaken for a subcohort of 156 individuals with no suboptimal health indicators.Results: Median age was 35 years, body mass index 23.4 kg/m2 and the glomerular filtration rate was 106 mL/min/1.73 m2. Median AG was 13 mmol/L and the reference interval for normal AG is 10–18 mmol/L with a 99% level of confidence. Statistically significant differences in AG were detected for sex, race, obesity and serum albumin, but the difference was 1 mmol/L between subgroups. The reference interval was the same for the sub‐cohort of 156 individuals. Median AGK was 17.7 mmol/L and reference interval was 14.6–22.5 mmol/L.Conclusions: The AG reference interval of 10–18 mmol/L is valid for laboratories with similar reference intervals for electrolytes. Lower values expected with current laboratory techniques were not observed. The median AG of 13 mmol/L may be used to differentiate gap acidosis, non‐gap acidosis or mixed acid–base disorders.